Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 20, 2010 - Issue 6
Submit an article Journal homepage
262
Views
46
CrossRef citations to date
0
Altmetric
Reviews

Dengue vaccines: state of the art

Sathyamangalam Swaminathan International Centre for Genetic Engineering & Biotechnology, Recombinant Gene Products Group, PO Box 10504, Aruna Asaf Ali Marg, New Delhi-110067, India +91 11 26742357 ext 271; +91 11 26742316; [email protected]
,
Gaurav Batra International Centre for Genetic Engineering & Biotechnology, Recombinant Gene Products Group, PO Box 10504, Aruna Asaf Ali Marg, New Delhi-110067, India +91 11 26742357 ext 271; +91 11 26742316; [email protected]
&
Navin Khanna International Centre for Genetic Engineering & Biotechnology, Recombinant Gene Products Group, PO Box 10504, Aruna Asaf Ali Marg, New Delhi-110067, India +91 11 26742357 ext 271; +91 11 26742316; [email protected]
Pages 819-835 | Published online: 13 Apr 2010

Citations (46)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Rahul Shukla, Viswanathan Ramasamy, Ravi Kant Rajpoot, Upasana Arora, Ankur Poddar, Richa Ahuja, Hemalatha Beesetti, Sathyamangalam Swaminathan & Navin Khanna. (2019) Next generation designer virus-like particle vaccines for dengue. Expert Review of Vaccines 18:2, pages 105-117.
Read now
Hemalatha Beesetti, Navin Khanna & Sathyamangalam Swaminathan. (2016) Investigational drugs in early development for treating dengue infection. Expert Opinion on Investigational Drugs 25:9, pages 1059-1069.
Read now
Hemalatha Beesetti, Navin Khanna & Sathyamangalam Swaminathan. (2014) Drugs for dengue: a patent review (2010 – 2014). Expert Opinion on Therapeutic Patents 24:11, pages 1171-1184.
Read now
Kin Fai Tang & Eng Eong Ooi. (2012) Diagnosis of dengue: an update. Expert Review of Anti-infective Therapy 10:8, pages 895-907.
Read now
Duane J Gubler. (2011) Emerging vector-borne flavivirus diseases: are vaccines the solution?. Expert Review of Vaccines 10:5, pages 563-565.
Read now

Articles from other publishers (41)

Kulkanya Chokephaibulkit, Yu-Wen Chien, Sazaly AbuBakar, Kovit Pattanapanyasat & Guey Chuen Perng. (2020) Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development. Viruses 12:11, pages 1261.
Crossref
Amudhan Murugesan, Dhanasezhian Aridoss, Swarna Senthilkumar, Lallitha Sivathanu, Ramalingam Sekar, Esaki M. Shankar & Elanchezhiyan Manickan. (2020) Molecular Diversity of Dengue Virus Serotypes 1–4 during an Outbreak of Acute Dengue Virus Infection in Theni, India. Indian Journal of Medical Microbiology 38:3-4, pages 401-408.
Crossref
Ravi Kant Rajpoot, Rahul Shukla, Upasana Arora, Sathyamangalam Swaminathan & Navin Khanna. (2018) Dengue envelope-based ‘four-in-one’ virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice. Scientific Reports 8:1.
Crossref
Robin B. McFee. (2018) Selected mosquito borne illnesses - Dengue. Disease-a-Month 64:5, pages 246-274.
Crossref
Rahul Shukla, Ravi K. Rajpoot, Upasana Arora, Ankur Poddar, Sathyamangalam Swaminathan & Navin Khanna. (2018) Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo. Frontiers in Microbiology 8.
Crossref
Viswanathan Ramasamy, Upasana Arora, Rahul Shukla, Ankur Poddar, Rajgokul K. Shanmugam, Laura J. White, Melissa M. Mattocks, Rajendra Raut, Ashiya Perween, Poornima Tyagi, Aravinda M. de Silva, Siddhartha K. Bhaumik, Murali Krishna Kaja, François Villinger, Rafi Ahmed, Robert E. Johnston, Sathyamangalam Swaminathan & Navin Khanna. (2018) A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice. PLOS Neglected Tropical Diseases 12:1, pages e0006191.
Crossref
Scott B. Halstead & Stephen J. Thomas. 2018. Plotkin's Vaccines. Plotkin's Vaccines 241 251.e6 .
Ankur Poddar, Viswanathan Ramasamy, Rahul Shukla, Ravi Kant Rajpoot, Upasana Arora, Swatantra K. Jain, Sathyamangalam Swaminathan & Navin Khanna. (2016) Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies. BMC Biotechnology 16:1.
Crossref
Neha Kaushik, Deepak Rohila, Upasana Arora, Rajendra Raut, Urpo Lamminmäki, Navin Khanna & Gaurav Batra. (2016) Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris. BMC Biotechnology 16:1.
Crossref
Hossein Fahimi, Majid Sadeghizadeh & Mahshid Mohammadipour. (2016) In silico analysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidate . Clinical and Experimental Vaccine Research 5:1, pages 41.
Crossref
Ruchi Sood, Rajendra Raut, Poornima Tyagi, Pawan Kumar Pareek, Tarani Kanta Barman, Smita Singhal, Raj Kumar Shirumalla, Vijay Kanoje, Ramesh Subbarayan, Ravisankar Rajerethinam, Navin Sharma, Anil Kanaujia, Gyanesh Shukla, Y. K. Gupta, Chandra K. Katiyar, Pradip K. Bhatnagar, Dilip J. Upadhyay, Sathyamangalam Swaminathan & Navin Khanna. (2015) Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes. PLOS Neglected Tropical Diseases 9:12, pages e0004255.
Crossref
Rolf Bauerfeind, Alexander von Graevenitz, Peter Kimmig, Hans Gerd Schiefer, Tino Schwarz, Werner Slenczka & Horst Zahner. 2015. Zoonoses. Zoonoses 1 174 .
Rajendra Raut, Hemalatha Beesetti, Poornima Tyagi, Ira Khanna, Swatantra K Jain, Variam U Jeankumar, Perumal Yogeeswari, Dharmarajan Sriram & Sathyamangalam Swaminathan. (2015) A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture. Virology Journal 12:1.
Crossref
Alienys Izquierdo, Angélica García, Laura Lazo, Lázaro Gil, Ernesto Marcos, Mayling Alvarez, Iris Valdés, Lisset Hermida, Gerardo Guillén & María G. Guzmán. (2014) A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice. Archives of Virology 159:10, pages 2597-2604.
Crossref
Shu-Wen Wan, Yi-Tien Lu, Chia-Hui Huang, Chiou-Feng Lin, Robert Anderson, Hsiao-Sheng Liu, Trai-Ming Yeh, Yu-Ting Yen, Betty A. Wu-Hsieh & Yee-Shin Lin. (2014) Protection against Dengue Virus Infection in Mice by Administration of Antibodies against Modified Nonstructural Protein 1. PLoS ONE 9:3, pages e92495.
Crossref
Niyati Khetarpal, Ankur Poddar, Satish K Nemani, Nisha Dhar, Aravind Patil, Priyanka Negi, Ashiya Perween, Ramaswamy Viswanathan, Heinrich Lünsdorf, Poornima Tyagi, Rajendra Raut, Upasana Arora, Swatantra K Jain, Ursula Rinas, Sathyamangalam Swaminathan & Navin Khanna. (2013) Dengue-specific subviral nanoparticles: design, creation and characterization. Journal of Nanobiotechnology 11:1.
Crossref
Robin B. McFee. (2013) Viral hemorrhagic fever viruses. Disease-a-Month 59:12, pages 410-425.
Crossref
Chia-Ling Chen, Chiou-Feng Lin, Shu-Wen Wan, Li-Shiung Wei, Mei-Chun Chen, Trai-Ming Yeh, Hsiao-Sheng Liu, Robert Anderson & Yee-Shin Lin. (2013) Anti–Dengue Virus Nonstructural Protein 1 Antibodies Cause NO-Mediated Endothelial Cell Apoptosis via Ceramide-Regulated Glycogen Synthase Kinase-3β and NF-κB Activation. The Journal of Immunology 191:4, pages 1744-1752.
Crossref
Chwan-Chuen King & Guey Perng. 2013. Viral Hemorrhagic Fevers. Viral Hemorrhagic Fevers 481 498 .
Tae-Geum Kim, Mi-Young Kim, Nguyen-Xuan Huy, Sae-Hae Kim & Moon-Sik Yang. (2012) M Cell-Targeting Ligand and Consensus Dengue Virus Envelope Protein Domain III Fusion Protein Production in Transgenic Rice Calli. Molecular Biotechnology 54:3, pages 880-887.
Crossref
Shailendra Mani, Lav Tripathi, Rajendra Raut, Poornima Tyagi, Upasana Arora, Tarani Barman, Ruchi Sood, Alka Galav, Wahala Wahala, Aravinda de Silva, Sathyamangalam Swaminathan & Navin Khanna. (2013) Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies. PLoS ONE 8:5, pages e64595.
Crossref
Kulkanya Chokephaibulkit & Guey Chuen Perng. (2013) Challenges for the formulation of a universal vaccine against dengue. Experimental Biology and Medicine 238:5, pages 566-578.
Crossref
P. M. S. CASTANHA, M. T. CORDEIRO, C. M. T. MARTELLI, W. V. SOUZA, E. T. A. MARQUESJr.Jr. & C. BRAGA. (2012) Force of infection of dengue serotypes in a population-based study in the northeast of Brazil. Epidemiology and Infection 141:5, pages 1080-1088.
Crossref
Mi-Young Kim, Nguyen-Duc Chung, Moon-Sik Yang & Tae-Geum Kim. (2012) Expression of a cholera toxin B subunit and consensus dengue virus envelope protein domain III fusion gene in transgenic rice callus. Plant Cell, Tissue and Organ Culture (PCTOC) 112:3, pages 311-320.
Crossref
Rosmari Rodriguez-Roche & Ernest A. Gould. (2013) Understanding the Dengue Viruses and Progress towards Their Control. BioMed Research International 2013, pages 1-20.
Crossref
Upasana Arora, Poornima Tyagi, Sathyamangalam Swaminathan & Navin Khanna. (2013) Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice. Vaccine 31:6, pages 873-878.
Crossref
Scott B. Halstead & Stephen J. Thomas. 2013. Vaccines. Vaccines 1042 1051 .
Sathyamangalam Swaminathan & Navin Khanna. 2013. Molecular Vaccines. Molecular Vaccines 135 151 .
Holly R Hughes, Wayne D Crill & Gwong-Jen J Chang. (2012) Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement. Virology Journal 9:1.
Crossref
Upasana Arora, Poornima Tyagi, Sathyamangalam Swaminathan & Navin Khanna. (2012) Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2. Journal of Nanobiotechnology 10:1.
Crossref
Anil Babu Korrapati, Gokul Swaminathan, Aarti Singh, Navin Khanna & Sathyamangalam Swaminathan. (2012) Adenovirus Delivered Short Hairpin RNA Targeting a Conserved Site in the 5′ Non-Translated Region Inhibits All Four Serotypes of Dengue Viruses. PLoS Neglected Tropical Diseases 6:7, pages e1735.
Crossref
Alienys Izquierdo, Iris Valdés, Lázaro Gil, Lisset Hermida, Sheila Gutiérrez, Angélica García, Lidice Bernardo, Alekis Pavón, Gerardo Guillén & María G. Guzmán. (2012) Serotype specificity of recombinant fusion protein containing domain III and capsid protein of dengue virus 2. Antiviral Research 95:1, pages 1-8.
Crossref
Mi-Young Kim, Moon-Sik Yang & Tae-Geum Kim. (2012) Expression of a consensus dengue virus envelope protein domain III in transgenic callus of rice. Plant Cell, Tissue and Organ Culture (PCTOC) 109:3, pages 509-515.
Crossref
Labib I. Faruque, Mahmudur Rahman, Emily S. Gurley, Stephen P. Luby, Rashid Uz Zaman, Rashidul Haque & A. S. M. Alamgir. (2012) Hospital-Based Prevalence of Malaria and Dengue in Febrile Patients in Bangladesh. The American Journal of Tropical Medicine and Hygiene 86:1, pages 58-64.
Crossref
Julia Schmitz, John Roehrig, Alan Barrett & Joachim Hombach. (2011) Next generation dengue vaccines: A review of candidates in preclinical development. Vaccine 29:42, pages 7276-7284.
Crossref
Yee-Shin Lin, Trai-Ming Yeh, Chiou-Feng Lin, Shu-Wen Wan, Yung-Chun Chuang, Tan-Kuei Hsu, Hsiao-Sheng Liu, Ching-Chuan Liu, Robert Anderson & Huan-Yao Lei. (2011) Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Experimental Biology and Medicine 236:5, pages 515-523.
Crossref
Brian R. MurphyStephen S. Whitehead. (2011) Immune Response to Dengue Virus and Prospects for a Vaccine. Annual Review of Immunology 29:1, pages 587-619.
Crossref
Luis Ángel Villar. (2011) Dengue: un reto para el estado, la comunidad científica y el conjunto de la sociedad colombiana. Infectio 15:1, pages 5-7.
Crossref
Guey Chuen Perng, Huan-Yao Lei, Yee-Shin Lin & Kulkanya Chokephaibulkit. (2011) Dengue Vaccines: Challenge and Confrontation. World Journal of Vaccines 01:04, pages 109-130.
Crossref
Duane J. Gubler. (2011) Dengue, Urbanization and Globalization: The Unholy Trinity of the 21st Century. Tropical Medicine and Health 39:4SUPPLEMENT, pages S3-S11.
Crossref
Eiji Konishi. (2011) Issues Related to Recent Dengue Vaccine Development. Tropical Medicine and Health 39:4SUPPLEMENT, pages S63-S71.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.